Fewer than one in five ACA brokers have read the actual text of Section 1557. Most operate on a rough summary: it says plans cannot discriminate. That is accurate as far as it goes, but the 2024 HHS final rule added specific obligations around gender identity, language access, and plan design that changed what brokers need to know when a client files a complaint or an employer asks about plan exclusions.
Key Takeaways
- Section 1557 of the ACA is the federal nondiscrimination rule for health programs receiving federal financial assistance. All Marketplace plans are covered. Most Medicaid-connected employer plans are covered. Self-funded employer plans with no federal funding nexus may not be covered.
- The 2024 HHS final rule (89 Fed. Reg. 37522, effective July 5, 2024) restored protections for gender identity and sexual orientation after the 2020 rule had narrowed them. Covered entities that dropped gender-affirming coverage exclusions between 2020 and 2024 may face retroactive compliance scrutiny.
- Language access requirements are active obligations, not best practices. A covered entity must provide written notice of the availability of language assistance services and must not charge the client for interpreter services.
- Section 1557 does not create a right to any particular benefit. It prohibits applying different benefit rules to similarly situated individuals because of a protected characteristic. A plan that excludes a service for everyone does not violate 1557; a plan that excludes the same service only for transgender enrollees likely does.
- Brokers who advise clients to avoid plans based on a protected characteristic, or who steer employers toward plan designs that discriminate, face both E&O and potential HHS complaint exposure even if the broker is not itself a covered entity.
What Section 1557 actually covers
Section 1557 of the ACA () applies the nondiscrimination protections of four existing federal civil rights statutes to any health program or activity that receives federal financial assistance from HHS. Those four statutes are Title VI of the Civil Rights Act (race, color, national origin), Title IX of the Education Amendments (sex), the Age Discrimination Act (age), and Section 504 of the Rehabilitation Act (disability).
The 2024 final rule, published at 89 Fed. Reg. 37522 and effective July 5, 2024, added gender identity and sexual orientation explicitly to the definition of sex under the regulation. This reversed the 2020 rule, which had narrowed the sex definition after the Supreme Court's Bostock v. Clayton County decision was handed down. HHS took the position in 2024 that Bostock's reasoning about Title VII applies to Title IX and therefore to Section 1557.
Which plans and entities are covered
The federal financial assistance nexus is the key trigger. For Marketplace plans, it is unambiguous: plans receive advance premium tax credit (APTC) payments from the federal government, which qualifies as federal financial assistance. All Marketplace plans are covered entities under Section 1557.
| Plan or entity type | Section 1557 covered? | Basis |
|---|---|---|
| Marketplace QHPs | Yes | APTC payments = federal financial assistance |
| Medicaid MCOs | Yes | Medicaid federal matching funds |
| Medicare Advantage plans | Yes | CMS MA capitation payments |
| Employer-sponsored plan (employer receives HHS grant) | Yes | HHS grant to the employer entity |
| Self-funded plan, no HHS funding | Disputed | No federal financial assistance to the plan itself |
| Short-term limited duration plans | No | Not QHPs, do not receive APTC |
Coverage status reflects the 2024 HHS final rule and federal court posture as of July 2026. Self-funded plan coverage is actively litigated; confirm with counsel before advising an employer with a self-funded plan.
The benefit design question
Section 1557 does not require covered entities to cover any particular service. A plan can exclude acupuncture, fertility treatment, or elective procedures across the board without triggering a 1557 claim. The violation occurs when a plan applies different benefit rules to similarly situated individuals because of a protected characteristic.
The gender-affirming care context is where this distinction has produced the most litigation. A plan that covers mastectomy for breast cancer and excludes mastectomy when the clinical indication is gender dysphoria is treating two diagnoses differently for the same procedure. Several federal district courts, including the Eighth and Tenth Circuits, have found that structure discriminatory under Section 1557. As of mid-2026, the circuit split on this issue means the outcome in any given jurisdiction depends on controlling precedent.
For brokers advising employer clients on plan design, the practical guidance is to flag any categorical exclusion that applies to a service differently based on diagnosis code rather than clinical indication. That pattern is the litigation target.
Language access obligations
The language access piece of Section 1557 is the one most likely to produce an enforcement action against a covered entity in the near term. The 2024 rule requires:
Covered entities must post a notice of the availability of language assistance in the 15 most common non-English languages spoken in the state. The notice must appear in the entity's patient-facing materials, significant publications, and on the entity's public website. HHS provides model notices by state and language on its website.
Covered entities must provide qualified oral interpretation at no charge to the client. Requiring a client to use a family member as interpreter violates the regulation, as does charging the client for an interpreter service. The practical issue for plan administrators is that many call center scripts still push clients toward having a family member translate rather than triggering the plan's interpretation service line.
For brokers whose clients are Marketplace enrollees with limited English proficiency, GetInsured and other enrollment platforms advertise multilingual support at the enrollment stage, but the Section 1557 obligation extends to ongoing plan communications throughout the plan year, not just enrollment. A client who files a claim dispute needs interpretation support at every step of the appeals process.
What brokers are responsible for
Most brokers are not themselves covered entities. A broker who does not operate within a covered entity's program and does not directly receive HHS financial assistance is generally outside the direct scope of Section 1557. The E&O exposure is indirect.
Two situations produce the clearest broker exposure. First, a broker who advises a client against enrolling in a plan or pursuing a claim based on a protected characteristic of the client. Second, a broker who advises an employer group client to adopt a plan design that contains a categorical exclusion targeting a protected class, without flagging the 1557 risk.
The intake question that catches the second scenario: when an employer asks about excluding a service from the plan, the broker's response should include whether the proposed exclusion is diagnosis-specific or procedure-specific, and whether the exclusion applies uniformly to all enrollees regardless of protected status.
When a client's plan may be violating 1557
The practical trigger for broker involvement is a client who is denied a covered service and suspects the denial is based on a protected characteristic rather than a clinical determination. The Section 1557 complaint pathway goes through HHS Office for Civil Rights (OCR). Clients can file at hhs.gov/ocr. The complaint must be filed within 180 days of the discriminatory act.
For Marketplace plan denials, the broker's immediate step is to determine whether the denial is a coverage determination (appealable through the plan's internal and external review process) or a categorical exclusion embedded in the plan documents. A categorical exclusion is not resolved through the standard internal appeals process; it requires either an HHS OCR complaint or litigation.
Brokers should not be providing legal advice on whether a specific denial constitutes a Section 1557 violation. The value-add at the broker level is knowing the difference between a clinical denial (use the appeals process) and a plan design exclusion (flag for an attorney or advocacy organization).
Frequently asked questions: Section 1557 nondiscrimination
Broker questions about the ACA nondiscrimination rule and what it means for plan selection and employer advice.
Which health plans are covered by Section 1557?
Any health program or activity that receives federal financial assistance from HHS is covered. This includes all Marketplace plans (they receive federal premium tax credit payments), Medicaid managed care organizations, Medicare Advantage plans, CHIP plans, and most community health centers. Employer-sponsored plans are covered if the employer receives any HHS financial assistance, including grants, contracts, or cooperative agreements. Purely self-funded ERISA plans with no HHS funding nexus have historically been the clearest exclusion, though HHS has signaled interest in expanding coverage through future rulemaking.
What did the 2024 HHS final rule change about Section 1557?
The 2024 final rule (effective July 5, 2024) reversed the 2020 rule's removal of gender identity and sexual orientation from the definition of sex discrimination. It also reinstated the requirement that covered entities adopt nondiscrimination notices and grievance procedures. The 2024 rule added explicit protections against discrimination based on sex stereotyping, pregnancy-related conditions, and, for the first time in regulation, against discrimination based on sexual orientation. It also clarified that categorical exclusions of gender-affirming care in covered entity plans likely constitute sex discrimination.
Does Section 1557 require a plan to cover gender-affirming care specifically?
Section 1557 does not mandate any specific covered benefit. It prohibits applying discriminatory benefit structures. A plan that excludes all cosmetic procedures for all enrollees does not violate 1557. A plan that excludes mastectomy or hormone therapy specifically for transgender enrollees while covering comparable procedures for cisgender enrollees does. The question is always whether similarly situated individuals are treated differently because of a protected characteristic. Several federal district courts have enjoined categorical exclusions of gender-affirming care in state employee plans under Section 1557, though the landscape is actively litigated as of mid-2026.
What are the language access requirements under Section 1557?
Covered entities must take reasonable steps to provide meaningful access for individuals with limited English proficiency (LEP). Required steps include providing qualified oral interpretation services, providing written translation of vital documents upon request, and posting a notice in the 15 most common languages spoken by LEP individuals in the state informing clients of the right to language assistance at no cost. The notice must appear in patient-facing materials, on websites, and in significant communications. HHS has model notices by state and language available. Charging a client for interpreter services or requiring them to use a family member as interpreter violates the regulation.
What is a broker's exposure under Section 1557?
Brokers are generally not themselves covered entities under Section 1557 unless they operate within a covered entity's program or receive HHS financial assistance directly. However, a broker who steers clients away from plans because of a protected characteristic, or who advises an employer to design a benefit structure that discriminates, can face E&O claims and HHS complaint referrals even without direct covered entity status. The cleaner exposure comes from advising a client on a plan's categorical exclusion without flagging that the exclusion may be a Section 1557 violation the client could appeal or escalate.
